Evidence map›Paper›PMID 29474916›Full record

ArticleCell2018

The Unexpected Effects of the Combination of Antibiotics and Immunity.

Thomas P Burke

Abstract readComment
PubMed Publisher
In one paragraph

Article in Cell, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Thomas P BurkeDepartment of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA. Electronic address: tburke@berkeley.edu.

Funding

Rickettsia mobilization of the cytoskeleton during invasion, motility, and spreadR01AI109044 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI WELCH, MATTHEW D · 2014 to 2025
$5.6M
Exploring the role of type I interferon in Rickettsia pathogenesisR21AI138550 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI WELCH, MATTHEW D · 2019 to 2020
$432k
NIAID NIH HHS R01 AI109044NIAID NIH HHS R21 AI138550
6 · The paper itself

Abstract

β-lactam antibiotics and immune enzymes, including lysozyme, kill bacteria by rupturing the cell wall. Curiously, their combination can select for viable, wall-less bacteria. Kawai and colleagues describe the molecular details regarding the emergence of these forms, illustrating a novel and potentially clinically relevant mechanism by which bacteria escape killing by antibiotics.

Indexed as

Anti-Bacterial Agentsbeta-LactamsBacteriaCell WallMuramidaseAnti-Bacterial Agentsbeta-LactamsMuramidase

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.